There were 1,544 press releases posted in the last 24 hours and 438,487 in the last 365 days.

The New Ireland Fund, Inc. Postpones Record Date for Rights Offering

/EINPresswire.com/ -- BOSTON, MA--(Marketwired - Oct 4, 2017) - The New Ireland Fund, Inc. (NYSE: IRL) (the "Fund"), a closed‐end investment company managed by KBI Global Investors (North America) Ltd. ("KBIGI"), announced today that the previously announced record date of October 16, 2017 for its proposed transferable rights offering has been postponed. The original record date was announced subject to effectiveness of a registration statement on file with the Securities and Exchange Commission. While the registration statement is expected to become effective, it is not yet effective. The Fund will announce a new record date following effectiveness of the registration statement. 

Before investing in the Fund, investors should carefully consider the investment objective, risks and expenses of the Fund. This information, including other information concerning the Fund, can be found on file with the U.S. Securities and Exchange Commission. An investor should carefully read the registration statement before investing.

A registration statement relating to these securities has been filed with the U.S. Securities and Exchange Commission but has not yet become effective. The information in the registration statement is not complete and may be changed. These securities may not be sold nor may offers be accepted prior to the time the registration statement becomes effective. This announcement is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

The New Ireland Fund, Inc.
(800) 468-6475
investor.query@newirelandfund.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.